Precision will be exhibiting at EACR virtual conference on November 18-19. Drop by our virtual booth to meet with the team, or send a message to https://www.precisionformedicine.com/contact-us/ to arrange a meeting
Also don’t miss Darren Davis (Senior Vice President) presentation available on-demand:
Utilizing Liquid Biopsy to Promote Successful Oncology Therapeutic Development
A common barrier to greater biomarker utilization in oncology clinical trials is the difficulty in obtaining tumor biopsies from patients. Join Precision for Medicine as we explore how to utilize liquid biopsies to accelerate oncology therapeutic development. Our presentation explores the clinical utility of CTCs and CTC biomarker data, discuss methods to effectively capture, image, and analyze CTCs, and will present a case study in melanoma, investigating whether CTCs could serve as an effective PD biomarker to support an adaptive trial design.
Precision for Medicine is part of the Precision Medicine Group, an integrated team of experts that extends Precision for Medicine’s therapeutic development capabilities beyond approval and into launch strategies, marketing communication, and payer insights. As one company, the Precision Medicine Group helps pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.
